The American Society of Nephrology’s philanthropic foundation, KidneyCure, will commit up to $6 million in bridge grants over ...

The ORIGIN Phase 3 trial met the primary endpoint with a statistically significant and clinically meaningful reduction in ...

Preclinical data for CLYM116, anti-APRIL monoclonal antibody, highlight favorable pharmacokinetic and pharmacodynamic profile ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...

Travere Therapeutics (TVTX) announced that the Company will present 11 abstracts, including a late-breaking poster, at the upcoming American ...

Meghan Gallagher is a Seattle-based freelance content writer and strategist. She has a B.S. in Marketing Management and a background in digital marketing for healthcare, nonprofit, and higher ...